Stephen Schaffer, MD
Otolaryngology · Anchorage, AKNPI 1720051089
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.2% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Intersect ENT, Inc. at 32.5% of the total. Reporting peaked in 2021 at $549 and has fallen 57.1% since, to $236 in 2025.
Across 40 payments — averaging $45.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$586
- Sanofi$272
- Stryker$227
- GSK$227
- Medtronic$197
- ADMA Biomanufacturing LLC$105
- plus $188 from 5 others
What the payments were for
- Consulting fees$1056%
- Food & beverage$1,69694%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 8 | $586 |
| Sanofi | 5 | $272 |
| Stryker | 7 | $227 |
| GSK | 9 | $227 |
| Medtronic | 4 | $197 |
| ADMA Biomanufacturing LLC | 1 | $105 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Aerin Medical Inc. | 1 | $42 |
| Integra Lifesciences Corporation | 1 | $40 |
| Smith+Nephew | 1 | $31 |
| Inspire Medical Systems, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$391
- SINUVA$265
- XPRESS ENT DILATION SYSTEM$139
- PROFESS$139
- DUPIXENT$132
How this compares
$1,801 in reported general payments places this provider in the 75th percentile of 20 otolaryngology providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 35 | $748 |
| Fluocinolone Acetonide Oil | 20 | $611 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $547 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $63 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Anchorage
- Eli BressAnchorage$2K
- Khang LuAnchorage$2K
- Christopher KowalskiAnchorage$2K
- Mark LorenzAnchorage$1K
- John KokeshAnchorage$604
- Amalia SteinbergAnchorage$596
- James AndrewsAnchorage$451
- Creed MamikunianAnchorage$421
- Jennifer WingateAnchorage$327
- Laura ShivelyAnchorage$213
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.